Jakafi and Demerol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Jakafi and Demerol. Common interactions include drug dependence among males.
The phase IV clinical study analyzes what interactions people who take Jakafi and Demerol have. It is created by eHealthMe based on reports of 8 people who take Jakafi and Demerol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8 people who take Jakafi and Demerol together, and have interactions are studied.
What is Jakafi?
Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 52,440 Jakafi users for its effectiveness, alternative drugs and more.
What is Demerol?
Demerol has active ingredients of meperidine hydrochloride. It is often used in pain. eHealthMe is studying from 12,155 Demerol users for its effectiveness, alternative drugs and more.
Number of Jakafi and Demerol reports submitted per year:
Common Jakafi and Demerol drug interactions by gender *:
female:
n/a
male:
- Drug dependence
- Suicide attempt
- Hospitalisation
* Approximation only. Some reports may have incomplete information.
Do you take Jakafi and Demerol?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Jakafi and Demerol:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Jakafi side effects:
- Fatigue (feeling of tiredness): 6,714 reports
- Death: 4,149 reports
- Thrombocytopenia (decrease of platelets in blood): 3,514 reports
- Dizziness: 3,170 reports
- Weakness: 2,809 reports
- Headache (pain in head): 2,604 reports
Browse all side effects of Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Demerol side effects:
- Pain: 1,582 reports
- Drug ineffective: 1,221 reports
- Nausea and vomiting: 1,049 reports
- Fatigue (feeling of tiredness): 962 reports
- Rashes (redness): 911 reports
- Stress and anxiety: 879 reports
Browse all side effects of Demerol:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Jakafi interactions:
- Jakafi and Aspirin: 9,697 reports
- Jakafi and Lopurin: 3,915 reports
- Jakafi and Allopurinol: 3,913 reports
- Jakafi and Lisinopril: 3,062 reports
- Jakafi and Amlodipine: 2,977 reports
- Jakafi and Omeprazole: 2,966 reports
- Jakafi and Hydroxyurea: 2,801 reports
- Jakafi and Gabapentin: 2,476 reports
- Jakafi and Multivitamin: 2,436 reports
- Jakafi and Prednisone: 2,397 reports
Browse all interactions between Jakafi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Demerol interactions:
- Demerol and Morphine: 2,259 reports
- Demerol and Prednisone: 1,535 reports
- Demerol and Morphine sulfate: 1,313 reports
- Demerol and Codeine: 1,287 reports
- Demerol and Phenergan: 1,200 reports
- Demerol and Tylenol: 1,170 reports
- Demerol and Humira: 1,033 reports
- Demerol and Dilaudid: 927 reports
- Demerol and Lyrica: 914 reports
- Demerol and Percocet: 891 reports
Browse all interactions between Demerol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ruxolitinib phosphate and meperidine hydrochloride (the active ingredients of Jakafi and Demerol, respectively), and Jakafi and Demerol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Jakafi and Demerol.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Brivaracetam and Pregnancy On Oral Contraceptive - 3 seconds ago
- Suboxone and Lidex drug interaction - 3 seconds ago
- Magnesium Sulfate and Peripheral Sensory Neuropathy - 5 seconds ago
- Neupogen and Blood Beta-D-Glucan Increased - 6 seconds ago
- Polyethylene Glycol 3350 and Dulcolax drug interaction - 6 seconds ago
- Agrylin and Blood Alkaline Phosphatase Increased - 14 seconds ago
- Vitamin C and Gastritis - 16 seconds ago
- Metformin vs. Humalog Pen - 22 seconds ago
- Terbinafine Hydrochloride and Depression - 23 seconds ago
- Velcade and Paroxysmal Supraventricular Tachycardia - 24 seconds ago